Success Metrics

Clinical Success Rate

100.0%

Based on 1 completed trials

Completion Rate

100%(1/1)

Active Trials

3(60%)

Results Posted

0%(0 trials)

Phase Distribution

Ph phase_2

20%

Ph not_applicable

60%

Ph phase_3

20%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution5 total trials

Phase 2Efficacy & side effects

1(20.0%)

Phase 3Large-scale testing

1(20.0%)

N/ANon-phased studies

3(60.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

1 of 1 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Active(3)

Completed(1)

Other(1)

Detailed Status

Recruiting3

unknown1

Completed1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

100.0%

Most Advanced

Phase 3

Trials by Phase

Phase 21 (20.0%)

Phase 31 (20.0%)

N/A3 (60.0%)

Trials by Status

recruiting360%

unknown120%

completed120%

Recent Activity

3 active trials

Showing 5 of 5

recruitingnot_applicable

European Study on Prediction of Outcome in Patients With Idiopathic Normal Pressure Hydrocephalus

NCT00874198

completedphase_2

Study to Evaluate Efficacy of Shunt Operation for Idiopathic Normal Pressure Hydrocephalus

NCT00221091

Clinical Trials (5)

Showing 5 of 5 trials

NCT04998175Not Applicable

Multi-omics Research of Idopathic Normal Pressure Hydrocephalus (iNPH)

Recruiting

NCT04177914Phase 3

HCRN Endoscopic Versus Shunt Treatment of Hydrocephalus in Infants

Recruiting

NCT05219331Not Applicable

Hydrocephalus Treatment on Persistent Disorder of Consciousness

Recruiting

NCT00874198Not Applicable

European Study on Prediction of Outcome in Patients With Idiopathic Normal Pressure Hydrocephalus

Unknown

NCT00221091Phase 2

Study to Evaluate Efficacy of Shunt Operation for Idiopathic Normal Pressure Hydrocephalus

Completed

All 5 trials loaded

Drug Details

Intervention Type: PROCEDURE
Total Trials: 5